Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression.
Preliminary studies have shown that polymorphonuclear neutrophil (PMN) activity is decreased in a state-dependent manner in patients with endogenous depression. The present study investigates this finding in a larger group of psychiatric patients and attempts to determine the identification of the factor responsible for the abnormal neutrophil function. Chemiluminescence responses of PMNs from patients with diagnoses of endogenous depression, panic disorder, anxiety, schizophrenia and alcoholism were assessed concurrently with age- and sex-matched control subjects. The reduction in PMN activity was observed in panic disorder patients as well as during depression but remained normal in schizophrenia, alcoholism and generalised anxiety. The defect in PMN function appears to be related to an abnormal factor in the serum of the patient which is corrected on clinical recovery. Aspirin-inhibited prostaglandin synthesis resulted in an enhancement of PMN activity in healthy subjects, suggesting a possible role for prostaglandins in the abnormal PMN response.
O'Neill
B
B
Institute of Clinical Pharmacology, Dublin, Ireland.
Leonard
B E
BE
D000437:Alcoholism / Q000175:diagnosis; D001008:Anxiety Disorders / Q000175:diagnosis; D001143:Arousal / Q000502:physiology; D003866:Depressive Disorder / Q000175:diagnosis* / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007108:Immune Tolerance / Q000276:immunology; D008163:Luminescent Measurements; D009504:Neutrophils / Q000276:immunology*; D010200:Panic / Q000502:physiology; D012559:Schizophrenia / Q000175:diagnosis; D015054:Zymosan
D015054:Zymosan; D006854:Hydrocortisone